NYSE:PKI - New York Stock Exchange, Inc. - US7140461093 - Common Stock - Currency: USD
115.24
-1.06 (-0.91%)
The current stock price of PKI is 115.24 USD. In the past month the price decreased by -15.23%. In the past year, price decreased by -21.46%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
DHR | DANAHER CORP | 28.07 | 151.18B | ||
A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
WAT | WATERS CORP | 31.58 | 22.26B | ||
ICLR | ICON PLC | 14.39 | 16.63B | ||
WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
RVTY | REVVITY INC | 23.23 | 13.85B | ||
AVTR | AVANTOR INC | 17.3 | 11.78B | ||
TEM | TEMPUS AI INC | N/A | 10.72B |
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.
PERKINELMER INC
940 Winter Street
Waltham MASSACHUSETTS 02451 US
CEO: Prahlad Singh
Employees: 16700
Company Website: https://www.perkinelmer.com/
Phone: 17816635776.0
The current stock price of PKI is 115.24 USD. The price decreased by -0.91% in the last trading session.
The exchange symbol of PERKINELMER INC is PKI and it is listed on the New York Stock Exchange, Inc. exchange.
PKI stock is listed on the New York Stock Exchange, Inc. exchange.
20 analysts have analysed PKI and the average price target is 159.39 USD. This implies a price increase of 38.31% is expected in the next year compared to the current price of 115.24. Check the PERKINELMER INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PERKINELMER INC (PKI) has a market capitalization of 14.57B USD. This makes PKI a Large Cap stock.
PERKINELMER INC (PKI) currently has 16700 employees.
PERKINELMER INC (PKI) has a resistance level at 127.47. Check the full technical report for a detailed analysis of PKI support and resistance levels.
The Revenue of PERKINELMER INC (PKI) is expected to decline by -31.32% in the next year. Check the estimates tab for more information on the PKI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PKI does not pay a dividend.
PERKINELMER INC (PKI) will report earnings on 2023-07-31, before the market open.
The PE ratio for PERKINELMER INC (PKI) is 14.51. This is based on the reported non-GAAP earnings per share of 7.94 and the current share price of 115.24 USD. Check the full fundamental report for a full analysis of the valuation metrics for PKI.
ChartMill assigns a fundamental rating of 4 / 10 to PKI. While PKI seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months PKI reported a non-GAAP Earnings per Share(EPS) of 7.94. The EPS decreased by -30.47% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 16.32% | ||
ROA | 5.28% | ||
ROE | 10.11% | ||
Debt/Equity | 0.53 |
ChartMill assigns a Buy % Consensus number of 73% to PKI. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of -34.36% and a revenue growth -31.32% for PKI